Resibufogenin administration prevents oxidative stress in a rat model of human preeclampsia.

Pathogenesis and promising non-invasive markers for preeclampsia. Obstet Gynecol Sci (2013) 0.80

Comparison of Neurocognitive Testing and the Measurement of Marinobufagenin in Mild Traumatic Brain Injury: A Preliminary Report. J Exp Neurosci (2015) 0.76

Synthetic Receptors Induce Anti Angiogenic and Stress Signaling on Human First Trimester Cytotrophoblast Cells. Int J Environ Res Public Health (2017) 0.75

ACC/AHA 2005 Practice Guidelines for the management of patients with peripheral arterial disease (lower extremity, renal, mesenteric, and abdominal aortic): a collaborative report from the American Association for Vascular Surgery/Society for Vascular Surgery, Society for Cardiovascular Angiography and Interventions, Society for Vascular Medicine and Biology, Society of Interventional Radiology, and the ACC/AHA Task Force on Practice Guidelines (Writing Committee to Develop Guidelines for the Management of Patients With Peripheral Arterial Disease): endorsed by the American Association of Cardiovascular and Pulmonary Rehabilitation; National Heart, Lung, and Blood Institute; Society for Vascular Nursing; TransAtlantic Inter-Society Consensus; and Vascular Disease Foundation. Circulation (2006) 13.21

ACC/AHA 2005 guidelines for the management of patients with peripheral arterial disease (lower extremity, renal, mesenteric, and abdominal aortic): executive summary a collaborative report from the American Association for Vascular Surgery/Society for Vascular Surgery, Society for Cardiovascular Angiography and Interventions, Society for Vascular Medicine and Biology, Society of Interventional Radiology, and the ACC/AHA Task Force on Practice Guidelines (Writing Committee to Develop Guidelines for the Management of Patients With Peripheral Arterial Disease) endorsed by the American Association of Cardiovascular and Pulmonary Rehabilitation; National Heart, Lung, and Blood Institute; Society for Vascular Nursing; TransAtlantic Inter-Society Consensus; and Vascular Disease Foundation. J Am Coll Cardiol (2006) 5.70

ACC/AHA Guidelines for the Management of Patients with Peripheral Arterial Disease (lower extremity, renal, mesenteric, and abdominal aortic): a collaborative report from the American Associations for Vascular Surgery/Society for Vascular Surgery, Society for Cardiovascular Angiography and Interventions, Society for Vascular Medicine and Biology, Society of Interventional Radiology, and the ACC/AHA Task Force on Practice Guidelines (writing committee to develop guidelines for the management of patients with peripheral arterial disease)--summary of recommendations. J Vasc Interv Radiol (2006) 3.59

Interleukin-6-driven progranulin expression increases cholangiocarcinoma growth by an Akt-dependent mechanism. Gut (2011) 1.91

Involvement of marinobufagenin in a rat model of human preeclampsia. Am J Nephrol (2005) 1.13

Preeclampsia. Part 1: clinical and pathophysiologic considerations. Obstet Gynecol Surv (2002) 1.11

A rat model of preeclampsia. Clin Exp Hypertens (2005) 0.98

Anandamide exerts its antiproliferative actions on cholangiocarcinoma by activation of the GPR55 receptor. Lab Invest (2011) 0.96

Examination of the cellular mechanisms by which marinobufagenin inhibits cytotrophoblast function. J Biol Chem (2008) 0.94

Resibufogenin corrects hypertension in a rat model of human preeclampsia. Exp Biol Med (Maywood) (2006) 0.92

Suppression of the HPA axis during extrahepatic biliary obstruction induces cholangiocyte proliferation in the rat. Am J Physiol Gastrointest Liver Physiol (2011) 0.91

Preeclampsia. Part 2: experimental and genetic considerations. Obstet Gynecol Surv (2002) 0.88

Marinobufagenin is an upstream modulator of Gadd45a stress signaling in preeclampsia. Biochim Biophys Acta (2010) 0.85

Marinobufagenin causes endothelial cell monolayer hyperpermeability by altering apoptotic signaling. Am J Physiol Regul Integr Comp Physiol (2009) 0.82

Uncoupled endothelial nitric oxide synthase and oxidative stress in a rat model of pregnancy-induced hypertension. Am J Hypertens (2007) 0.81

Vascular leak in a rat model of preeclampsia. Am J Nephrol (2009) 0.81

Resibufogenin prevents the manifestations of preeclampsia in an animal model of the syndrome. Hypertens Pregnancy (2010) 0.79

A chemifluorescent immunoassay for the determination of marinobufagenin in body fluids. J Immunoassay Immunochem (2011) 0.79

Phenotypic characteristics shared by preeclamptic patients and an animal model of the syndrome: report of a pilot study. Am J Hypertens (2006) 0.78

Marinobufagenin levels in preeclamptic patients: a preliminary report. Am J Perinatol (2011) 0.78

Suppression of aldosterone and progesterone in preeclampsia. J Matern Fetal Neonatal Med (2014) 0.78

Genetic variation in solute carrier genes is associated with preeclampsia. Am J Obstet Gynecol (2010) 0.78

Marinobufagenin interferes with the function of the mineralocorticoid receptor. Biochem Biophys Res Commun (2007) 0.78

Alterations in the renin-angiotensin system in a rat model of human preeclampsia. Am J Nephrol (2009) 0.77

Beneficial effects of metolazone in a rat model of preeclampsia. J Pharmacol Exp Ther (2006) 0.77

Trauma in patients with continuous-flow left ventricular assist devices. Am J Cardiol (2013) 0.76

Bivalirudin for treatment of aortic valve thrombosis after left ventricular assist device implantation. ASAIO J (2013) 0.76

62-year-old-female with weakness and shortness of breath. Am J Med Sci (2009) 0.75

The treatment of preeclampsia in a rat model employing Digibind. Am J Perinatol (2009) 0.75

A 73-year-old-man with fever and weight loss. Am J Med Sci (2010) 0.75